Dr. Kamel is the Vice Chair for Research and Chief of Neurocritical Care in the Department of Neurology at Weill Cornell Medicine. He is also the Director of the Clinical and Translational Neuroscience Unit in the Feil Family Brain and Mind Research Institute and the Department of Neurology at Weill Cornell Medicine. His research focuses on the relationship between cardiac disease and stroke. He was a principal investigator and protocol lead for the NIH-funded ARCADIA trial, which tested antithrombotic strategies in patients with stroke and atrial cardiopathy. He is a principal investigator of the NIH-funded ASPIRE trial, which is testing antithrombotic strategies in patients with atrial fibrillation and intracerebral hemorrhage. He co-directs the Weill Cornell Laboratory for Understanding Cerebral Injury via Imaging and Data Science (LUCID), which is conducting several NIH-funded studies to develop cutting-edge imaging techniques for neurological disorders. He has published over 350 scientific publications, including in leading journals such as NEJM and JAMA.

Dr. Kamel attended college at Harvard and medical school at Columbia, then trained as a neurology resident and neurocritical care fellow at the University of California, San Francisco before joining Weill Cornell Medicine in 2011. He has a master’s degree from the Columbia University Data Science Institute and has led multiple studies involving novel uses of large-scale administrative healthcare data to better understand a variety of topics including cardiovascular complications of pregnancy, liver disease, and sepsis.

Dr. Kamel is co-chair of the NIH StrokeNet Prevention Working Group, co-chair of the Multi-Ethnic Study of Atherosclerosis Brain Working Group, and a steering committee member of the international AF-SCREEN collaboration. He served on the writing committee for the American Heart Association’s most recent Secondary Stroke Prevention Guidelines. He serves on the leadership committees of several multicenter randomized trials, including STROKE-AF, Librexia AF, REACT-AF, and LAAOS-4. He is the Deputy Editor of JAMA Neurology and an editorial board member of Stroke. His academic contributions have been recognized by the Michael S. Pessin Stroke Leadership Prize from the American Academy of Neurology and the Robert G. Siekert New Investigator Award in Stroke and the Joseph A. Vita Award from the American Heart Association.